Back to today’s briefing

Story perspectives

Pfizer's Recall Sparks Syphilis Treatment Crisis, FDA Responds

7/18/2025

23 1

Summary

Story summary

Pfizer's recall of Bicillin L-A, a vital penicillin for treating syphilis in pregnant women, has thrown the U.S. supply into turmoil as newborn syphilis cases surge. This recall, prompted by contamination concerns, affects several lots and is likely to lead to temporary shortages. In response, the FDA is permitting imports of alternative penicillin to alleviate the crisis.

1 of 1

Story summary

Pfizer's recall of Bicillin L-A, a vital penicillin for treating syphilis in pregnant women, has thrown the U.S. supply into turmoil as newborn syphilis cases surge. This recall, prompted by contamination concerns, affects several lots and is likely to lead to temporary shortages. In response, the FDA is permitting imports of alternative penicillin to alleviate the crisis.